BF-RhodoLED
Device Dermatology
PDI 04260308240102
General payments
$774,632
Research payments
$2,666,196
Through program year 2025, $774,632 in general payments and $2,666,196 in research payments were reported against BF-RhodoLED (Dermatology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $11,421 | 287 |
| 2025 | Research | $737,730 | 128 |
| 2024 | General | $249,165 | 5,335 |
| 2024 | Research | $380,753 | 32 |
| 2023 | General | $205,727 | 5,565 |
| 2023 | Research | $646,055 | 25 |
| 2022 | General | $193,694 | 4,310 |
| 2022 | Research | $522,754 | 24 |
| 2021 | General | $114,626 | 3,476 |
| 2021 | Research | $378,904 | 64 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
18,973 general · 273 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.